Home/Filings/4/0001179110-17-008651
4//SEC Filing

Editas Medicine, Inc. 4

Accession 0001179110-17-008651

$EDITCIK 0001650664operating

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:09 PM ET

Size

6.0 KB

Accession

0001179110-17-008651

Insider Transaction Report

Form 4
Period: 2017-06-02
Transactions
  • Purchase

    Common Stock

    2017-06-02$14.07/sh+35,000$492,52735,000 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,649,572
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.9 per share to $14.15 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F2]These shares are owned by bng0, LLC. Boris Nikolic, as a member and the managing director of bng0, LLC, has voting and investment power over such shares and may be deemed the indirect beneficial owner of such shares. Boris Nikolic disclaims beneficial ownership over such shares, except to the extent of any pecuniary interest therein.

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001650664

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:09 PM ET
Size
6.0 KB